Identifying Drug-Therapy Problems among Syrian Refugees in Zaatari Refugee Camp.
Alaa Mahmoud HammadWalid A Al-QeremFawaz AlAsmariJonathan LingRaghda QarqazHakam AlaqabaniPublished in: International journal of environmental research and public health (2022)
Background: Due to a lack of proper pharmaceutical care, Syrian refugees in the Zaatari refugee camp are more likely to have drug-related issues, such as prescription errors and adverse drug occurrences. Aim: The current study aims to identify drug-therapy problems among Syrian refugees in the Zaatari refugee camp. Method: This is a retrospective cross-sectional study. Patients' files were collected from the Zaatari camp database. Patients who were 18 years or older and were previously diagnosed with a chronic disease were included. A classification of drug therapy problems (DTPs) was adapted. Results: The data of 1530 adult patients (896 females) were collected. The mean age of the sample was 53.7 years and the mean Body mass Index (BMI) was 27.20. The mean of all taken medications was 4.01 (±2.33) medications, with a maximum number of 13. A total of 3572 DTPs was identified, with a mean of 2.33 (±1.26) DTPs per patient. Based on the above-mentioned classification, 70.32% of the DTPs were related to indication, 26.65% were related to effectiveness, and 3.03% were related to safety. Conclusion: This study found that refugees in the Zaatari refugee camp have numerous DTPs among their medications. Greater focus should be placed on their medical care, in order to prevent any future complications due to DTPs.
Keyphrases
- adverse drug
- body mass index
- mental health
- drug induced
- electronic health record
- binding protein
- end stage renal disease
- deep learning
- emergency department
- randomized controlled trial
- systematic review
- chronic kidney disease
- protein kinase
- palliative care
- weight gain
- quality improvement
- health insurance
- prognostic factors
- weight loss
- patient safety
- big data
- current status
- peritoneal dialysis
- replacement therapy
- patient reported
- affordable care act